Ozempic Cuts Kidney Risk By 24%

Novo Nordisk HQ
• Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

More from Clinical Trials

More from R&D